Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002–2016

Abstract

Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control armAbstract Background: Epidemiologic data have shown an increasing incidence and declining mortality rate in sepsis. However, confounding effects due to differences in disease classification might have contributed to these trends. To assess if a declining mortality over time could be supported by data derived from high-quality prospective studies, we performed a meta-analysis using data from randomised controlled trials (RCTs) on sepsis. The primary aim was to assess whether the mortality in sepsis trials has changed over time. The secondary aim was to investigate how many of the included trials could show efficacy of the studied intervention regarding 28-day mortality.Methods: We searched PubMed for RCTs enrolling patients with severe sepsis and septic shock, published between 2002 and 2016. The included trials were assessed for quality and sorted by date of first inclusion. A meta-analysis was performed to synthesise data from the individual sepsis trials.Results: Of 418 eligible articles, 44 RCTs on sepsis were included in the analysis, enrolling 13,315 patients in the usual care arm between 1991 and 2013. In this time period, mortality decreased by 0.42% annually (p = 0.04) to give a total decline of 9.24%. In subgroup analyses with adjustments for APACHE II, SAPS II and SOFA scores, the observed time trend was not significant (p = 0.45, 0.23 and 0.98 respectively). Only four of the included trials showed any efficacy with regard to mortality.Conclusions: Data from RCTs show a declining trend in 28-day mortality in severe sepsis and septic shock patients during the years from 1991 to 2013. However, when controlling for severity at study inclusion, there was no significant change in mortality over time. The number of trials presenting new treatment options was low.

Accuracy of circulating microRNAs in diagnosis of sepsis: a systematic review and meta-analysis

“…Sepsis is defined as a life-threatening condition of organ dysfunction resulted from a dysregulated host response to infection [ 1 ]. Recent epidemiologic data have shown an increasing incidence of sepsis and septic shock with high mortality [ 2 ]. Although recent data suggested a declining trend in mortality, longer-term morbidity and decreased health-related quality of life remain a serious problem [ 3 ].…”

Pre-Hospital Lactatemia Predicts 30-Day Mortality in Patients with Septic Shock—Preliminary Results from the LAPHSUS Study

“…This represents around 20% of all global deaths [ 3 ] and one-third to one-half of all in-hospital deaths [ 4 ]. Despite recent advances in the treatment of sepsis and SS (septic shock), the mortality rate in patients admitted to the intensive care unit (ICU) remains stable, ranging from 10 to 20% for sepsis and from 50 to 60% for SS [ 5 , 6 , 7 ]. In 2016, the “sepsis 3” conference and the Center for Disease Control and Prevention emphasized that early recognition, severity assessment and early treatment were priorities in order to improve the survival of patients with sepsis [ 8 ].…”

Relative platelet reduction provides a better pathophysiologic signature of coagulopathy in sepsis than absolute platelet count: A large multicenter eICU database analysis

“…Sepsis is a major concern in the eld of critical care and occurs from an uncontrolled and dysregulated immune response against infection, which causes multiple organ dysfunction (1). For decades, the survival rate of patients with sepsis has not signi cantly improved, despite several randomized control trials (RCTs) on new treatment modalities and improved compliance with treatment guidelines (2)(3)(4).…”